About Event
Join the 6th Glioblastoma Drug Development Summit to Collaborate & Connect with Experts in GBM from Pharma, Biotechs, Academia & Investment Firms to Take Steps Towards a Crucial Treatment
No matter what stage of development or therapeutic modality you are working on, the upcoming Glioblastoma Drug Development Summit will be the essential event for advancing GBM therapies.
With the persistent unmet need in this devastating disease, the 6th Glioblastoma Drug Development Summit will return as a vital platform to showcase groundbreaking scientific innovations and strategic insights, aiming to bring life-saving treatments closer to reality.
This unique event will convene leading experts from pharmaceutical giants, cutting-edge biotech companies, and renowned academic institutions, alongside neurosurgeons, KOLs, investors and search & evaluation experts. Together, they will focus on accelerating the delivery of new glioblastoma therapies to the market, fostering collaboration, and overcoming the challenges that have long stalled progress. Whether you are working on novel therapeutic approaches or enhancing clinical trial designs, this Summit will provide invaluable opportunities to engage with decision-makers, gain insights, and push the boundaries of GBM drug development.
Join Your Peers to:
Explore the innovative ways to overcome the blood-brain barrier with experts from the Focused Ultrasound Foundation and AbbVie. Discover cutting-edge delivery techniques that enable the direct transport of therapeutic agents to tumors, unlocking new possibilities in glioblastoma treatment.
Learn how Genenta and Incephalo are reshaping immunotherapy for glioblastoma by flipping the tumor microenvironment. See how they’re turning immune-resistant "cold" tumors "hot," creating new strategies for tackling immune evasion.
Join a liquid biopsy expert from NYU Langone as they explore the complexities of pseudoprogression in GBM and gliomas. Learn about the emerging field of radiopharmaceutical theranostics for neuro-oncology in partnership with Telix Pharmaceuticals
Engage with a panel of investors and evaluation specialists from the GBM space as they set new standards for partnerships, acquisitions, and investment strategies. Connect, showcase your work, and gain key insights into attracting funding to drive breakthroughs in neuro-oncology.
Who Will You Meet?
The 6th Glioblastoma Drug Development Summit will be a unique industry-led forum, bringing together 90+ leaders from large pharma, biotech, neuro-oncology, clinical practice, investment, and academia, all united by a shared mission: to transform the landscape of drug development for glioblastoma and other CNS tumors. This unique event focuses on advancing the delivery of effective therapies in a treatment-agnostic environment, driving progress toward breakthrough solutions.
“This Summit brings a wide-range of like-minded key leaders in Neuro-Oncology offering exceptional presentations from target discovery to clinical trial design in addition to an abundance of networking opportunities with investors, advocates, and leading researchers.” - Chief Executive Officer & Co-Founder
“GBM is a deadly disease and any attempt to move the needle is worth pursuing. This summit is an excellent platform to interact with leaders in the field in a focused setting that is super exciting.” - Vice President, Research & Development
